Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy
- 31 December 2004
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 97 (3), 517-520
- https://doi.org/10.1016/j.ijcard.2003.12.003
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Immunohistological Changes in Dilated Cardiomyopathy Induced by Immunoadsorption Therapy and Subsequent Immunoglobulin SubstitutionCirculation, 2001
- Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathyJournal of the American College of Cardiology, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of CardiomyopathiesCirculation, 1996
- A Synthetic Peptide Corresponding to the Second Extracellular Loop of the Human M2 Acetylcholine Receptor Induces Pharmacological and Morphological Changes in Cardiomyocytes by Active Immunization after 6 Months in RabbitsClinical Immunology and Immunopathology, 1996
- Soluble Interleukin-2 Receptor Levels in Patients With Dilated CardiomyopathyCirculation, 1995
- Transfer of human myocarditis into severe combined immunodeficiency mice.Circulation Research, 1994
- Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect.Circulation, 1994
- Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function.Circulation, 1990
- Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy.Circulation Research, 1989